SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2184166

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2184166

AI-Enabled Adaptive Radiotherapy Systems Market Forecasts to 2034 - Global Analysis By Component (Hardware, Software and Services), Imaging Modality, Technology, Adaptive Workflow, Application, End User and By Geography

PUBLISHED:
PAGES: 300+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global AI-Enabled Adaptive Radiotherapy Systems Market is accounted for $1.5 billion in 2026 and is expected to reach $5.8 billion by 2034 growing at a CAGR of 18.4% during the forecast period. The AI-Enabled Adaptive Radiotherapy Systems Market encompasses advanced radiation oncology technologies that integrate artificial intelligence, medical imaging, and adaptive treatment planning to modify radiation delivery according to changing patient anatomy. Increasing cancer prevalence, growing demand for precision radiotherapy, and advancements in automated treatment workflows are supporting market development. Innovations in AI-based contouring, image registration, and dose optimization improve treatment efficiency. Expanding oncology infrastructure and healthcare investment create additional growth opportunities.

Market Dynamics:

Driver:

Increasing cancer prevalence and growing adoption of AI-assisted precision radiotherapy

Increasing cancer prevalence and growing adoption of AI-assisted precision radiotherapy are driving market growth. Conventional radiotherapy planning can require extensive manual contouring and repeated treatment adjustments when patient anatomy changes. AI-enabled adaptive systems support automated image segmentation, treatment planning, and dose optimization to improve workflow efficiency. Growing demand for personalized radiation treatment encourages investment in advanced imaging and guidance technologies. Improvements in machine learning algorithms and clinical integration further support adoption across specialized oncology centers.

Restraint:

High equipment costs and complex integration with existing radiotherapy infrastructure

High equipment costs and complex integration with existing radiotherapy infrastructure restrain market growth. AI-enabled adaptive radiotherapy systems require substantial investment in advanced linear accelerators, imaging equipment, treatment planning software, and specialized computing infrastructure. Implementation involves staff training, clinical workflow redesign, and extensive quality assurance procedures. Differences in hospital information systems and radiotherapy platforms can complicate interoperability. Limited technical expertise and constrained healthcare budgets further restrict adoption, particularly among smaller treatment facilities and developing markets.

Opportunity:

Expansion of automated online adaptive radiotherapy and AI-driven treatment optimization

Expansion of automated online adaptive radiotherapy and AI-driven treatment optimization presents significant growth opportunities. Healthcare providers are increasingly investigating technologies that enable rapid treatment plan modification based on daily anatomical changes. Advances in AI-assisted contouring, deformable image registration, and automated dose calculation can reduce planning time and improve clinical workflow consistency. Growing adoption of image-guided radiotherapy supports integration of adaptive capabilities. Strategic collaborations among medical equipment manufacturers, software developers, and oncology institutions encourage further innovation.

Threat:

Algorithm reliability concerns and increasing regulatory scrutiny of AI-based medical systems

Algorithm reliability concerns and increasing regulatory scrutiny of AI-based medical systems pose significant challenges to market development. Adaptive radiotherapy requires accurate image interpretation, reliable anatomical segmentation, and precise dose calculations to maintain patient safety. Algorithm errors, dataset bias, and inconsistent performance across patient populations may affect clinical confidence. Cybersecurity risks and software interoperability challenges create additional concerns. Regulatory approval requirements, reimbursement uncertainty, and competition from established radiotherapy technologies may further influence market adoption.

Covid-19 Impact:

The COVID-19 pandemic disrupted radiation oncology services through delayed cancer diagnoses, restricted hospital operations, and interruptions in medical equipment supply chains. Treatment centers faced staffing shortages and challenges maintaining routine radiotherapy schedules. These disruptions encouraged greater interest in workflow automation, remote treatment planning, and efficient clinical resource utilization. AI-assisted radiotherapy technologies gained attention for their potential to streamline planning and reduce manual workload. Post-pandemic recovery in oncology services and expanding investment in digital healthcare continue to support market development.

The hardware segment is expected to be the largest during the forecast period

The hardware segment is expected to account for the largest market share during the forecast period due to substantial investment in advanced linear accelerators, imaging systems, and integrated treatment delivery equipment. Adaptive radiotherapy requires high-precision radiation platforms supported by accurate anatomical imaging and patient positioning technologies. Growing installation of cone-beam CT-guided and MRI-guided radiotherapy systems encourages equipment demand. Advances in integrated imaging, automated positioning, and treatment delivery capabilities improve clinical performance. Expanding oncology infrastructure further strengthens segment prospects.

The AI-based auto-contouring & segmentation segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-based auto-contouring & segmentation segment is predicted to witness the highest growth rate due to increasing demand for automated anatomical delineation and efficient radiotherapy planning. These technologies utilize machine learning algorithms to identify tumors and organs at risk from medical images. Growing adoption of online adaptive workflows encourages demand for rapid segmentation capabilities. Advances in deep learning, imaging integration, and automated quality assurance support innovation. Expanding clinical validation could accelerate adoption across radiation oncology facilities.

Region with largest share:

During the forecast period, North America is expected to hold the largest market share due to advanced radiation oncology infrastructure, substantial healthcare expenditure, and widespread adoption of precision treatment technologies. The United States and Canada support AI-enabled adaptive radiotherapy through specialized cancer centers, academic medical institutions, and medical technology companies. Growing investment in image-guided radiotherapy and automated treatment planning encourages regional development. Established reimbursement frameworks and ongoing clinical research further strengthen North America's market position.

Region with highest CAGR:

Over the forecast period, Asia Pacific is anticipated to exhibit the highest CAGR, supported by expanding oncology infrastructure, increasing cancer treatment demand, and growing investment in advanced radiotherapy technologies. China, Japan, South Korea, India, and Australia are modernizing radiation treatment facilities and strengthening medical imaging capabilities. Government-supported healthcare initiatives and expanding hospital networks encourage adoption. Improvements in AI-based treatment planning, equipment accessibility, and specialized oncology training are expected to accelerate regional market growth.

Key players in the market

Some of the key players in the AI-Enabled Adaptive Radiotherapy Systems Market include Siemens Healthineers AG, Elekta AB, Accuray Incorporated, RaySearch Laboratories AB, Brainlab SE, GE HealthCare Technologies Inc., Koninklijke Philips N.V., United Imaging Healthcare Co., Ltd., Ion Beam Applications S.A., MIM Software Inc., MVision AI Oy, TheraPanacea SAS, Radformation, Inc., Limbus AI Inc., Mirada Medical Limited, DOSIsoft SA, Spectronic Medical AB, and ViewRay Systems, Inc.

Key Developments:

In September 2026, Accuray Incorporated and Samsung NeuroLogica announced progress in their collaboration to advance volumetric imaging capabilities for the CyberKnife radiotherapy platform. The initiative aims to strengthen image guidance and treatment precision through improved imaging integration, supporting the development of more advanced radiation oncology workflows.

In September 2026, Elekta AB announced an expansion of its adaptive radiotherapy portfolio at ASTRO 2026. The development included CT-guided and MRI-guided adaptive capabilities, online adaptive functionality for Elekta Harmony, and real-time adaptive planning for prostate brachytherapy. These innovations aim to improve treatment personalization and broaden access to adaptive radiotherapy across different clinical settings.

In September 2026, RaySearch Laboratories AB announced an expanded collaboration with Accuray Incorporated to integrate RayStation treatment planning software with Accuray radiotherapy platforms. The initiative initially focuses on the Radixact system, with planned expansion to CyberKnife, supporting faster online adaptive treatment planning and improved integration of imaging, planning, and treatment delivery.

Components Covered:

  • Hardware
  • Software
  • Services

Imaging Modalities Covered:

  • Cone-Beam Computed Tomography (CBCT)-Guided Systems
  • Magnetic Resonance Imaging (MRI)-Guided Systems
  • Computed Tomography (CT)-Guided Systems
  • Other Imaging Modalities

Technologies Covered:

  • AI-Based Auto-Contouring & Segmentation
  • Automated Treatment Planning & Optimization
  • Deformable Image Registration
  • AI-Based Dose Calculation & Prediction
  • Other Technologies

Adaptive Workflows Covered:

  • Online Adaptive Radiotherapy
  • Offline Adaptive Radiotherapy
  • Real-Time Adaptive Radiotherapy
  • Other Adaptive Workflows

Applications Covered:

  • Prostate Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Breast Cancer
  • Gastrointestinal Cancers
  • Gynecological Cancers
  • Other Applications

End Users Covered:

  • Hospitals
  • Cancer Treatment Centers
  • Academic Medical Centers
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC41824

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global AI-Enabled Adaptive Radiotherapy Systems Market, By Component

  • 5.1 Hardware
    • 5.1.1 Linear Accelerator Systems
    • 5.1.2 Imaging & Guidance Systems
  • 5.2 Software
    • 5.2.1 AI-Based Treatment Planning Software
    • 5.2.2 Adaptive Workflow Management Software
  • 5.3 Services

6 Global AI-Enabled Adaptive Radiotherapy Systems Market, By Imaging Modality

  • 6.1 Cone-Beam Computed Tomography (CBCT)-Guided Systems
  • 6.2 Magnetic Resonance Imaging (MRI)-Guided Systems
  • 6.3 Computed Tomography (CT)-Guided Systems
  • 6.4 Other Imaging Modalities

7 Global AI-Enabled Adaptive Radiotherapy Systems Market, By Technology

  • 7.1 AI-Based Auto-Contouring & Segmentation
  • 7.2 Automated Treatment Planning & Optimization
  • 7.3 Deformable Image Registration
  • 7.4 AI-Based Dose Calculation & Prediction
  • 7.5 Other Technologies

8 Global AI-Enabled Adaptive Radiotherapy Systems Market, By Adaptive Workflow

  • 8.1 Online Adaptive Radiotherapy
  • 8.2 Offline Adaptive Radiotherapy
  • 8.3 Real-Time Adaptive Radiotherapy
  • 8.4 Other Adaptive Workflows

9 Global AI-Enabled Adaptive Radiotherapy Systems Market, By Application

  • 9.1 Prostate Cancer
  • 9.2 Lung Cancer
  • 9.3 Head & Neck Cancer
  • 9.4 Breast Cancer
  • 9.5 Gastrointestinal Cancers
  • 9.6 Gynecological Cancers
  • 9.7 Other Applications

10 Global AI-Enabled Adaptive Radiotherapy Systems Market, By End User

  • 10.1 Hospitals
  • 10.2 Cancer Treatment Centers
  • 10.3 Academic Medical Centers
  • 10.4 Other End Users

11 Global AI-Enabled Adaptive Radiotherapy Systems Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Siemens Healthineers AG
  • 14.2 Elekta AB
  • 14.3 Accuray Incorporated
  • 14.4 RaySearch Laboratories AB
  • 14.5 Brainlab SE
  • 14.6 GE HealthCare Technologies Inc.
  • 14.7 Koninklijke Philips N.V.
  • 14.8 United Imaging Healthcare Co., Ltd.
  • 14.9 Ion Beam Applications S.A.
  • 14.10 MIM Software Inc.
  • 14.11 MVision AI Oy
  • 14.12 TheraPanacea SAS
  • 14.13 Radformation, Inc.
  • 14.14 Limbus AI Inc.
  • 14.15 Mirada Medical Limited
  • 14.16 DOSIsoft SA
  • 14.17 Spectronic Medical AB
  • 14.18 ViewRay Systems, Inc.
Product Code: SMRC41824

List of Tables

  • Table 1 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 4 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Linear Accelerator Systems (2023-2034) ($MN)
  • Table 5 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Imaging & Guidance Systems (2023-2034) ($MN)
  • Table 6 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Software (2023-2034) ($MN)
  • Table 7 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By AI-Based Treatment Planning Software (2023-2034) ($MN)
  • Table 8 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Adaptive Workflow Management Software (2023-2034) ($MN)
  • Table 9 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Services (2023-2034) ($MN)
  • Table 10 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Imaging Modality (2023-2034) ($MN)
  • Table 11 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Cone-Beam Computed Tomography (CBCT)-Guided Systems (2023-2034) ($MN)
  • Table 12 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Magnetic Resonance Imaging (MRI)-Guided Systems (2023-2034) ($MN)
  • Table 13 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Computed Tomography (CT)-Guided Systems (2023-2034) ($MN)
  • Table 14 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Other Imaging Modalities (2023-2034) ($MN)
  • Table 15 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Technology (2023-2034) ($MN)
  • Table 16 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By AI-Based Auto-Contouring & Segmentation (2023-2034) ($MN)
  • Table 17 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Automated Treatment Planning & Optimization (2023-2034) ($MN)
  • Table 18 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Deformable Image Registration (2023-2034) ($MN)
  • Table 19 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By AI-Based Dose Calculation & Prediction (2023-2034) ($MN)
  • Table 20 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 21 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Adaptive Workflow (2023-2034) ($MN)
  • Table 22 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Online Adaptive Radiotherapy (2023-2034) ($MN)
  • Table 23 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Offline Adaptive Radiotherapy (2023-2034) ($MN)
  • Table 24 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Real-Time Adaptive Radiotherapy (2023-2034) ($MN)
  • Table 25 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Other Adaptive Workflows (2023-2034) ($MN)
  • Table 26 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 27 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 28 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 29 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Head & Neck Cancer (2023-2034) ($MN)
  • Table 30 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 31 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Gastrointestinal Cancers (2023-2034) ($MN)
  • Table 32 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Gynecological Cancers (2023-2034) ($MN)
  • Table 33 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 34 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 35 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 36 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Cancer Treatment Centers (2023-2034) ($MN)
  • Table 37 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Academic Medical Centers (2023-2034) ($MN)
  • Table 38 Global AI-Enabled Adaptive Radiotherapy Systems Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!